You just read:

More Than $224 Million Raised by U.S. Life Sciences Companies Through At-The-Market (ATM) Offerings in 2011 vs. $184 Million in 2010, Brinson Patrick Reports

News provided by

Brinson Patrick Securities Corporation

Apr 10, 2012, 08:00 ET